Squarepoint’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $8.89M | Buy |
181,978
+171,297
| +1,604% | +$8.37M | 0.01% | 600 |
|
2025
Q1 | $544K | Sell |
10,681
-23,290
| -69% | -$1.19M | ﹤0.01% | 1857 |
|
2024
Q4 | $1.53M | Sell |
33,971
-297,736
| -90% | -$13.4M | ﹤0.01% | 1295 |
|
2024
Q3 | $12.3M | Buy |
331,707
+208,817
| +170% | +$7.75M | 0.02% | 437 |
|
2024
Q2 | $3.76M | Buy |
+122,890
| New | +$3.76M | 0.01% | 788 |
|
2023
Q4 | – | Sell |
-13,500
| Closed | -$303K | – | 2855 |
|
2023
Q3 | $303K | Buy |
+13,500
| New | +$303K | ﹤0.01% | 1926 |
|
2023
Q1 | – | Sell |
-64,967
| Closed | -$2.48M | – | 2673 |
|
2022
Q4 | $2.48M | Sell |
64,967
-74,456
| -53% | -$2.84M | 0.01% | 703 |
|
2022
Q3 | $7M | Buy |
139,423
+49,584
| +55% | +$2.49M | 0.04% | 365 |
|
2022
Q2 | $3.6M | Buy |
89,839
+42,783
| +91% | +$1.71M | 0.02% | 531 |
|
2022
Q1 | $1.76M | Buy |
+47,056
| New | +$1.76M | 0.01% | 867 |
|
2021
Q2 | – | Sell |
-6,271
| Closed | -$297K | – | 2948 |
|
2021
Q1 | $297K | Buy |
+6,271
| New | +$297K | ﹤0.01% | 1886 |
|
2020
Q4 | – | Sell |
-13,638
| Closed | -$638K | – | 2808 |
|
2020
Q3 | $638K | Buy |
13,638
+8,109
| +147% | +$379K | 0.01% | 1172 |
|
2020
Q2 | $281K | Sell |
5,529
-4,326
| -44% | -$220K | ﹤0.01% | 1594 |
|
2020
Q1 | $440K | Buy |
+9,855
| New | +$440K | 0.01% | 1106 |
|
2019
Q4 | – | Sell |
-29,613
| Closed | -$1M | – | 2615 |
|
2019
Q3 | $1M | Buy |
+29,613
| New | +$1M | 0.01% | 1206 |
|
2019
Q2 | – | Sell |
-40,685
| Closed | -$1.53M | – | 2529 |
|
2019
Q1 | $1.53M | Sell |
40,685
-1,602
| -4% | -$60.3K | 0.02% | 883 |
|
2018
Q4 | $1.45M | Buy |
42,287
+13,087
| +45% | +$449K | 0.02% | 777 |
|
2018
Q3 | $1.37M | Sell |
29,200
-12,957
| -31% | -$609K | 0.02% | 849 |
|
2018
Q2 | $1.42M | Buy |
42,157
+12,480
| +42% | +$421K | 0.02% | 756 |
|
2018
Q1 | $803K | Buy |
29,677
+340
| +1% | +$9.2K | 0.01% | 884 |
|
2017
Q4 | $489K | Buy |
+29,337
| New | +$489K | 0.01% | 1215 |
|
2017
Q3 | – | Sell |
-21,049
| Closed | -$386K | – | 1812 |
|
2017
Q2 | $386K | Buy |
+21,049
| New | +$386K | 0.01% | 1037 |
|
2017
Q1 | – | Sell |
-41,643
| Closed | -$454K | – | 1835 |
|
2016
Q4 | $454K | Buy |
41,643
+15,165
| +57% | +$165K | 0.02% | 891 |
|
2016
Q3 | $371K | Buy |
+26,478
| New | +$371K | 0.02% | 661 |
|
2016
Q2 | – | Sell |
-50,800
| Closed | -$327K | – | 1302 |
|
2016
Q1 | $327K | Buy |
50,800
+43,700
| +615% | +$281K | 0.03% | 795 |
|
2015
Q4 | $230K | Sell |
7,100
-6,800
| -49% | -$220K | 0.03% | 917 |
|
2015
Q3 | $371K | Buy |
+13,900
| New | +$371K | 0.09% | 229 |
|
2015
Q2 | – | Sell |
-10,000
| Closed | -$609K | – | 576 |
|
2015
Q1 | $609K | Buy |
+10,000
| New | +$609K | 0.21% | 153 |
|